Paroxetine and neonatal withdrawal syndrome

BMJ Case Reports

Volumn , Issue , 2010, Pages

  Pogliani, Laura ^a   Schneider, Laura ^a   Dilillo, Dario ^a   Penagini, Francesca ^a   Zuccotti, Gian Vincenzo ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84897585585     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr.12.2009.2528     Document Type: Article

References (12)

1. Bennett HA, Einarson A, Taddio A, et al. Prevalence of depression during pregnancy: systematic review. Obstet Gynecol 2004; 103: 698-709. [Medline] [Web of Science] (Pubitemid 40459031)
2. Hendrick V, Smith LM, Suri R, et al. Birth outcomes after prenatal exposure to antidepressant medication. Am J Obstet Gynecol 2003; 188: 812-5. [CrossRef] [Medline] [Web of Science] (Pubitemid 36332456)
3. Chun-Fai-Chan B, Koren G, Fayez I, et al. Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study. Am J Obstet Gynecol 2005; 192: 932-6. [CrossRef] [Medline] [Web of Science] (Pubitemid 40311292)
4. Simon GE, Cunningham ML, Davis RL. Outcomes of prenatal antidepressant exposure. Am J Psychiatry 2002; 159: 2055-61. [CrossRef] [Medline] [Web of Science] (Pubitemid 35423865)
5. Chambers CD, Johnson KA, Dick LM, et al. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 1996; 335: 1010-5. [CrossRef] [Medline] [Web of Science] (Pubitemid 26338730)
6. Sanz EJ, las-Cuevas C, Kiuru A, et al. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet 2005; 365: 482-7. [CrossRef] [Medline] [Web of Science] (Pubitemid 40215730)
7. Chambers CD, Hernandez-Diaz S, Van Marter LJ, et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 2006; 354: 579-87. [CrossRef] [Medline] [Web of Science] (Pubitemid 43209105)
8. Kallen B. Neonate characteristics after maternal use of antidepressants in late pregnancy. Arch Pediatr Adolesc Med 2004; 158: 312-16. [CrossRef] [Medline] [Web of Science] (Pubitemid 38451555)
9. Isbister GK, Dawson A, Whyte IM, et al. Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome? Arch Dis Child Fetal Neonatal Ed 2001; 85: F147-8. [Medline] (Pubitemid 32816629)
10. Costei AM, Kozer E, Ho T, et al. Perinatal outcome following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med 2002; 156: 1129-32. [Medline] [Web of Science] (Pubitemid 36343460)
11. Bonari L, Pinto N, Ahn E, et al. Perinatal risks of untreated depression during pregnancy. Can J Psychiatry 2004; 49: 726-35. [Medline] (Pubitemid 40100521)
12. Cohen LS, Altshuler LL, Harlow BL, et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 2006; 295: 499-507. [CrossRef] [Medline] [Web of Science] (Pubitemid 43200344)